Skip to main content

CapForce Inc.

CFOR
Exchange
OTC
Industry
Services-Medical Laboratories
SEC CIK
0001293818

No open-market purchases or sales by CapForce Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding CapForce Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of CFOR: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders2616−10
SharesConverted for a 1-for-20 split107.2K248.0K+140.8K (+131.4%)
Value$521.8K$329.2K−$192.5K (−36.9%)

New holders (4)

Institutions that held CapForce Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to CFOR in Q1 2023
InstitutionSharesValue% of portfolio
Virtu Financial LLC48,331$64.0K0.01%
Dimensional Fund Advisors LP36,979$49.2K0.00%
Citadel Advisors LLC13,955$18.6K0.00%
Valley National Advisers Inc25$00.00%

Sold out (14)

Institutions that held CapForce Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of CFOR in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
HRT Financial LP191,437$26.0K
Renaissance Technologies LLC173,400$24.0K
State Street Corp129,200$18.2K
Ergoteles LLC128,748$18.2K
Northern Trust Corp69,789$9.84K
Two Sigma Advisers, LP34,000$4.79K
Bank of New York Mellon Corp28,242$3.98K
Great Valley Advisor Group, Inc.25,100$3.54K
Goldman Sachs Group Inc20,638$2.91K
Jane Street Group, LLC19,309$2.72K
Sigma Planning Corp17,500$2.47K
Millennium Management LLC11,304$2.00K
Morgan Stanley7,010$988
FMR LLC1,000$141